Wolfgang Bethge
Wolfgang Bethge
Medical Center University Hospital of Tuebingen
Verified email at med.uni-tuebingen.de
Title
Cited by
Cited by
Year
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open …
J Finke, WA Bethge, C Schmoor, HD Ottinger, M Stelljes, AR Zander, ...
The lancet oncology 10 (9), 855-864, 2009
6162009
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell …
T Feuchtinger, K Opherk, WA Bethge, MS Topp, FR Schuster, ...
Blood, The Journal of the American Society of Hematology 116 (20), 4360-4367, 2010
4282010
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party …
N Kröger, E Holler, G Kobbe, M Bornhäuser, R Schwerdtfeger, ...
Blood, The Journal of the American Society of Hematology 114 (26), 5264-5270, 2009
4002009
Antilymphocyte globulin for prevention of chronic graft-versus-host disease
N Kröger, C Solano, C Wolschke, G Bandini, F Patriarca, M Pini, A Nagler, ...
New England Journal of Medicine 374 (1), 43-53, 2016
3702016
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius
G Socié, C Schmoor, WA Bethge, HD Ottinger, M Stelljes, AR Zander, ...
Blood, The Journal of the American Society of Hematology 117 (23), 6375-6382, 2011
2852011
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies
ML Sorror, BM Sandmaier, BE Storer, GN Franke, GG Laport, ...
Jama 306 (17), 1874-1883, 2011
2732011
Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell …
V Icheva, S Kayser, D Wolff, S Tuve, C Kyzirakos, W Bethge, J Greil, ...
J Clin Oncol 31 (1), 39-48, 2013
2302013
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia
B Gyurkocza, R Storb, BE Storer, TR Chauncey, T Lange, JA Shizuru, ...
Journal of clinical oncology 28 (17), 2859, 2010
2162010
Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation
R Storb, B Gyurkocza, BE Storer, ML Sorror, K Blume, D Niederwieser, ...
Journal of Clinical Oncology 31 (12), 1530, 2013
2082013
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia
H Pfeifer, B Wassmann, W Bethge, J Dengler, M Bornhäuser, M Stadler, ...
Leukemia 27 (6), 1254-1262, 2013
1932013
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
C Kahl, BE Storer, BM Sandmaier, M Mielcarek, MB Maris, KG Blume, ...
Blood, The Journal of the American Society of Hematology 110 (7), 2744-2748, 2007
1722007
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders
GG Laport, BM Sandmaier, BE Storer, BL Scott, MJ Stuart, T Lange, ...
Biology of Blood and Marrow Transplantation 14 (2), 246-255, 2008
1582008
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update
WA Bethge, C Faul, M Bornhäuser, G Stuhler, DW Beelen, P Lang, ...
Blood Cells, Molecules, and Diseases 40 (1), 13-19, 2008
1562008
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
WA Bethge, U Hegenbart, MJ Stuart, BE Storer, MB Maris, MED Flowers, ...
Blood 103 (3), 790-795, 2004
1472004
Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors
R Handgretinger, A Geiselhart, A Moris, R Grau, O Teuffel, W Bethge, ...
New England Journal of Medicine 340 (4), 278-284, 1999
1381999
Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: a prospective randomized phase III study …
N Kroger, S Iacobelli, G Franke, U Platzbecker, R Uddin, K Hubel, ...
1362017
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
NR Mathew, F Baumgartner, L Braun, D O'Sullivan, S Thomas, ...
Nature medicine 24 (3), 282-291, 2018
1302018
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study
B Federmann, M Bornhauser, C Meisner, L Kordelas, DW Beelen, ...
haematologica 97 (10), 1523, 2012
1252012
Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis
H Alchalby, A Badbaran, T Zabelina, G Kobbe, J Hahn, D Wolff, ...
Blood, The Journal of the American Society of Hematology 116 (18), 3572-3581, 2010
1232010
Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device
M Schumm, P Lang, W Bethge, C Faul, T Feuchtinger, M Pfeiffer, W Vogel, ...
Cytotherapy 15 (10), 1253-1258, 2013
1182013
The system can't perform the operation now. Try again later.
Articles 1–20